<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="T1" position="float">
 <label>Table 1</label>
 <caption>
  <p>Origins of resistance in malaria parasite, 
   <italic>Plasmodium falciparum</italic>, to monotherapy drugs.
  </p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th valign="top" rowspan="1" colspan="1">Monotherapy application dates</th>
    <th valign="top" rowspan="1" colspan="1">Drug and its mechanism</th>
    <th valign="top" rowspan="1" colspan="1">Resistance and its mechanism</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td valign="top" rowspan="1" colspan="1">
     <bold>∼1930–1950</bold>
    </td>
    <td valign="top" rowspan="1" colspan="1">Chloroquine interferes with the detoxification of heme by accumulating in the digestive vacuole of 
     <italic>Plasmodium</italic> (
     <xref rid="B50" ref-type="bibr">Haldar et al., 2018</xref>).
    </td>
    <td valign="top" rowspan="1" colspan="1">∼1950. Mutations in transporter genes enabling efflux of chloroquine: chloroquine resistance transporter (PfCRT) (
     <xref rid="B74" ref-type="bibr">Martin et al., 2009</xref>) (
     <xref rid="B50" ref-type="bibr">Haldar et al., 2018</xref>); chloroquine transporter (CG2) (
     <xref rid="B50" ref-type="bibr">Haldar et al., 2018</xref>); ABC transporter (PfMDR1) (
     <xref rid="B50" ref-type="bibr">Haldar et al., 2018</xref>).
    </td>
   </tr>
   <tr>
    <td valign="top" rowspan="1" colspan="1">
     <bold>1953</bold>
    </td>
    <td valign="top" rowspan="1" colspan="1">Pyrimethamine and sulfadoxine inhibit folate pathway (
     <xref rid="B48" ref-type="bibr">Gregson and Plowe, 2005</xref>; 
     <xref rid="B55" ref-type="bibr">Hyde, 2005</xref>) by blocking dihydropteroate synthase (PfDhps) and dihydrofolate reductase (PfDhfr).
    </td>
    <td valign="top" rowspan="1" colspan="1">2009 (
     <xref rid="B46" ref-type="bibr">Gesase et al., 2009</xref>). Mutations in and/or amplification of PfDhps and PfDhfr genes (
     <xref rid="B93" ref-type="bibr">Shah et al., 2011</xref>; 
     <xref rid="B23" ref-type="bibr">Costa et al., 2017</xref>).
    </td>
   </tr>
   <tr>
    <td valign="top" rowspan="1" colspan="1">
     <bold>∼1960</bold>
    </td>
    <td valign="top" rowspan="1" colspan="1">Piperaquine interferes with the detoxification of heme by accumulating in the digestive vacuole of 
     <italic>Plasmodium</italic> (
     <xref rid="B36" ref-type="bibr">Eastman and Fidock, 2009</xref>).
    </td>
    <td valign="top" rowspan="1" colspan="1">2010 (
     <xref rid="B35" ref-type="bibr">Duru et al., 2016</xref>). Amplification of parasite protease genes, such as plasmepsin 2 and 3 (
     <xref rid="B50" ref-type="bibr">Haldar et al., 2018</xref>).
    </td>
   </tr>
   <tr>
    <td valign="top" rowspan="1" colspan="1">
     <bold>1972</bold>
    </td>
    <td valign="top" rowspan="1" colspan="1">Artemisinin suggested to interfere with the detoxification of heme (
     <xref rid="B36" ref-type="bibr">Eastman and Fidock, 2009</xref>).
    </td>
    <td valign="top" rowspan="1" colspan="1">2008 (
     <xref rid="B30" ref-type="bibr">Dondorp et al., 2009</xref>). Mutations in transporter genes, such as PfK13, enabling efflux of Chloroquine; or a change in target recognized by the parasite (
     <xref rid="B86" ref-type="bibr">Ouji et al., 2018</xref>).
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
